The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
Genetically related Mycobacterium tuberculosis strains with alterations at codon 516 in the rpoB gene were observed amongst a substantial number of patients with drug resistant tuberculosis in the Eastern Cape Province (ECP) of South Africa. Mutations at codon 516 are usually associated with lower l...
Main Authors: | Frederick A Sirgel, Robin M Warren, Erik C Böttger, Marisa Klopper, Thomas C Victor, Paul D van Helden |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3602005?pdf=render |
Similar Items
-
Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.
by: Frederick A Sirgel, et al.
Published: (2015-01-01) -
Transmission of MDR and XDR tuberculosis in Shanghai, China.
by: Ming Zhao, et al.
Published: (2009-01-01) -
INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01) -
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01) -
The burden of MDR/XDR tuberculosis in coastal plains population of China.
by: Xiujun Yang, et al.
Published: (2015-01-01)